BioLife Solutions Inc (BLFS)
Return on equity (ROE)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -20,184 | -68,002 | -139,805 | -8,908 | 1,983 |
| Total stockholders’ equity | US$ in thousands | 348,909 | 337,663 | 364,188 | 478,047 | 204,429 |
| ROE | -5.78% | -20.14% | -38.39% | -1.86% | 0.97% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $-20,184K ÷ $348,909K
= -5.78%
Based on the data provided for BioLife Solutions Inc, the return on equity (ROE) has shown a declining trend over the years from 2020 to 2024.
In 2020, the ROE was 0.97%, indicating that for every dollar of shareholders' equity, the company generated a return of 0.97 cents. However, by the end of 2021, the ROE dropped to -1.86%, signifying that the company was experiencing a loss relative to the shareholders' equity.
The situation worsened in the following years, with the ROE continuing to deteriorate. By the end of 2022, the ROE plummeted to -38.39%, indicating significant losses compared to the shareholders' equity. In 2023, the ROE further declined to -20.14%, reflecting ongoing challenges in generating profitability from the equity investment.
Although there was a slight improvement in 2024, with the ROE reaching -5.78%, the company still struggled to achieve a positive return on equity. Overall, the decreasing trend in ROE over the years suggests that BioLife Solutions Inc faced difficulties in efficiently utilizing shareholders' equity to generate profits and create value for its investors.
Peer comparison
Dec 31, 2024